ANI PHARMACEUTICALS, INC Other Non-Current Liabilities
ANI PHARMACEUTICALS, INC (ANIP) had Other Non-Current Liabilities of $15.54 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-07
- 2026-06-30: Other Liabilities, Noncurrent $15.54M.
- 2026-03-31: Other Liabilities, Noncurrent $16.45M.
- 2025-12-31: Other Liabilities, Noncurrent $12.16M.
- 2025-09-30: Other Liabilities, Noncurrent $11.27M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $15.54M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $16.45M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $12.16M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $11.27M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $6.70M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $7.02M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $5.78M 10-K · filed 2026-02-27 |
| 2024-09-30 | $6.94M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $4.68M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $5.05M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $4.81M 10-K · filed 2025-02-28 |
| 2023-09-30 | $5.26M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $4.73M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.20M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $1.38M 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.49M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.01M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $860.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $7.80M 10-K · filed 2023-03-09 |
| 2021-09-30 | $8.12M 10-Q · filed 2021-11-01 |
| 2021-06-30 | $9.26M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $8.38M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $14.48M 10-K · filed 2022-03-15 |
| 2020-09-30 | $16.42M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $17.08M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $13.61M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $6.51M 10-K · filed 2021-03-11 |
| 2019-09-30 | $8.06M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $6.77M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $3.11M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $496.00K 10-K · filed 2020-02-27 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |